Vivos Therapeutics
(NASDAQ) VVOS
Vivos Therapeutics Financials at a Glance
Market Cap
$13.82M
Revenue (TTM)
$17.32M
Net Income (TTM)
$17.10M
EPS (TTM)
$-1.97
P/E Ratio
-0.67
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$1.27
Volume
2,724
Open
$1.31
Price
$1.27
Volume
2,724
Open
$1.31
Previous Close
$1.27
Daily Range
$1.27 - $1.31
52-Week Range
$1.08 - $7.95
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$1.27
Volume
2,724
Open
$1.31
Previous Close
$1.27
Daily Range
$1.27 - $1.31
52-Week Range
$1.08 - $7.95
VVOS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vivos Therapeutics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
109
CEO
R. Kirk Huntsman
Website
www.vivos.comHeadquarters
Highlands Ranch, CO 80129, US
VVOS Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
-91%
Net Income Margin
-99%
Return on Equity
-335%
Return on Capital
-87%
Return on Assets
-67%
Earnings Yield
-1.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.82M
Shares Outstanding
10.47M
Volume
2.72K
Short Interest
0.00%
Avg. Volume
122.51K
Financials (TTM)
Gross Profit
$9.02M
Operating Income
$11.17M
EBITDA
$10.55M
Operating Cash Flow
$12.69M
Capital Expenditure
$568.00K
Free Cash Flow
$13.26M
Cash & ST Invst.
$6.26M
Total Debt
$1.51M
Vivos Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.78M
+75.7%
Gross Profit
$3.94M
+68.7%
Gross Margin
58.04%
N/A
Market Cap
$13.82M
N/A
Market Cap/Employee
$126.77K
N/A
Employees
109
N/A
Net Income
$5.40M
-106.4%
EBITDA
$5.02M
-100.7%
Quarterly Fundamentals
Net Cash
$9.41M
-301.6%
Accounts Receivable
$2.13M
+370.0%
Inventory
$0.00
N/A
Long Term Debt
$11.37M
+881.9%
Short Term Debt
$1.13M
+132.6%
Return on Assets
-66.70%
N/A
Return on Invested Capital
-86.57%
N/A
Free Cash Flow
$3.27M
+17.8%
Operating Cash Flow
$4.16M
+0.6%